Patents, Grants & Awards

US Patents

US Patents

Cytopeutics is a Malaysian stem cell company granted with several USA Patents for acute stroke, diabetes and macular oedema treatment with cell-based composition, as well as local patents for treatment involving heart, stroke, diabetes, autoimmune disease, critical limb ischemia and eye disease.

  • Acute Stroke [No. 10,278,993]
  • Diabetes [No.11,052,119]
  • Vernal Keratoconjunctivitis [NO. 10,828,332]

US Patent for Acute Stroke
No. 10,278,993

US Patent for Diabetes
No. 11,052,119

US Patent for Vernal Keratoconjunctivitis
No. 10,828,332

Malaysia Patents

Malaysia Patent for Heart copy

Malaysia Patent for Heart
No. MY- 171690-A

Malaysia Patern for Stroke copy

Malaysia Patent for Stroke
No. MY-173966-A

Malaysia Patern for Diabetes copy

Malaysia Patent for Diabetes
No. MY-171193-A

Malaysia Patern for Macular Oedema copy

Malaysia Patent for Macular Oedema
No. MY-171311-A

Malaysia Patern for Vernal Keratoconjunctivitis copy

Malaysia Patent for Vernal Keratoconjunctivitis
No. MY- 173386-A



(Ministry of Health Malaysia)

AHIN 2017_Grand Finalist Certificate-01

IPO Award Finalist

syariah complient cert-1

Syariah Compliant


Malaysia Health and Wellness Brand Awards 2017 – 2019
Endorsed by Ministry of Health, Malaysia

Best Brands in Biotechnology Cell-Based Research & Treatment 2015-2016
by Brand Laureate

Medical Technology – Health & Beauty Awards 2015-2016
by Long Life Magazine

SME 100 Awards 2015 Fast Moving Companies
by SME & Entrepreneurship Magazine

Malaysia Health and wellness brand awards 2017/2018/2019
Endorsed by Ministry of Health, Malaysia

Best brand in biotechnology cell-based research & treatment 2015-2016

Long Life Magazine
Health and Beauty Awards 2015-2016

SME100 Awards
Fast moving companies